SALIX PHARMACEUTICALS LTD Stock-Based Compensation
SALIX PHARMACEUTICALS LTD reported Stock-Based Compensation of $41.45 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for the quarter ending 2014-12-31 was $13.86M, a 89.33% increase year-over-year.
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for the quarter ending 2014-09-30 was $11.15M, a 63.57% increase year-over-year.
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for the quarter ending 2014-06-30 was $9.11M, a 30.61% increase year-over-year.
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for the quarter ending 2014-03-31 was $7.32M, a 45.43% increase year-over-year.
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for fiscal 2014 was $41.45M, a 58.50% increase from fiscal 2013.
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for fiscal 2013 was $26.15M, a 23.36% increase from fiscal 2012.
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for fiscal 2012 was $21.20M, a 34.26% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD share-based payment arrangement, noncash expense for fiscal 2011 was $15.79M, a 58.87% increase from fiscal 2010.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2014-12-31 | $13.86M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $25.02M derived: sum of 2 quarters · filed 2015-03-02 | $34.13M derived: sum of 3 quarters · filed 2015-03-02 | $41.45M 10-K · filed 2015-03-02 |
| 2014-09-30 | $11.15M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | $20.27M derived: sum of 2 quarters · filed 2015-03-02 | $27.59M 10-Q/A · filed 2015-03-02 | $34.91M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-06-30 | $9.11M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $16.44M 10-Q/A · filed 2015-03-02 | $23.76M derived: sum of 3 quarters · filed 2015-03-02 | $30.58M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-03-31 | $7.32M 10-Q/A · filed 2015-03-02 | $14.65M derived: sum of 2 quarters · filed 2015-03-02 | $21.46M derived: sum of 3 quarters · filed 2015-03-02 | $28.44M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-12-31 | $7.32M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $14.14M derived: sum of 2 quarters · filed 2015-03-02 | $21.12M derived: sum of 3 quarters · filed 2015-03-02 | $26.15M 10-K · filed 2015-03-02 |
| 2013-09-30 | $6.82M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | $13.80M derived: sum of 2 quarters · filed 2015-03-02 | $18.83M 10-Q/A · filed 2015-03-02 | $25.13M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $6.98M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $12.01M 10-Q/A · filed 2015-03-02 | $18.31M derived: sum of 3 quarters · filed 2015-03-02 | $23.90M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $5.04M 10-Q/A · filed 2015-03-02 | $11.34M derived: sum of 2 quarters · filed 2015-03-02 | $16.92M derived: sum of 3 quarters · filed 2015-03-02 | $22.25M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $11.88M derived: sum of 2 quarters · filed 2015-03-02 | $17.21M derived: sum of 3 quarters · filed 2015-03-02 | $21.20M 10-K · filed 2015-03-02 |
| 2012-09-30 | $5.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $10.91M derived: sum of 2 quarters · filed 2013-11-08 | $14.90M 10-Q · filed 2013-11-08 | $19.15M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-06-30 | $5.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $9.32M 10-Q · filed 2013-08-09 | $13.57M derived: sum of 3 quarters · filed 2015-03-02 | $17.70M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-03-31 | $3.99M 10-Q · filed 2013-05-10 | $8.24M derived: sum of 2 quarters · filed 2015-03-02 | $12.37M derived: sum of 3 quarters · filed 2015-03-02 | $16.99M derived: sum of 4 quarters · filed 2015-03-02 |
| 2011-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $8.38M derived: sum of 2 quarters · filed 2015-03-02 | $13.00M derived: sum of 3 quarters · filed 2015-03-02 | $15.79M 10-K · filed 2015-03-02 |
| 2011-09-30 | $4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $8.75M derived: sum of 2 quarters · filed 2012-11-08 | $11.54M 10-Q · filed 2012-11-08 | $14.47M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $7.41M 10-Q · filed 2012-08-09 | $10.34M derived: sum of 3 quarters · filed 2013-03-01 | $13.20M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $2.79M 10-Q · filed 2012-05-08 | $5.72M derived: sum of 2 quarters · filed 2013-03-01 | $8.58M derived: sum of 3 quarters · filed 2013-03-01 | $10.66M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $5.78M derived: sum of 2 quarters · filed 2013-03-01 | $7.87M derived: sum of 3 quarters · filed 2013-03-01 | $9.94M 10-K · filed 2013-03-01 |
| 2010-09-30 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $4.94M derived: sum of 2 quarters · filed 2011-11-09 | $7.01M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $4.16M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $2.07M 10-Q · filed 2011-05-10 | |||
| 2009-12-31 | $6.44M 10-K · filed 2012-02-28 |